Highlights
-
Today’s Research Article: Steroids may fade fast—see why PRP is stealing the spotlight in frozen shoulder treatment.
-
Questions from the Field: Knee injections got you guessing? Here’s how much PRP volume top docs are really drawing.
-
Let’s Get Down to Business: Is your practice running at peak performance? These 5 tips could be game-changers.
-
Come Join Us: Mark your calendar—these live events are where the future of orthobiologics is happening
If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.
Today’s Research Article
Comparing the Efficacy of Intra-articular Platelet-Rich Plasma and Corticosteroid Injections in the Management of Frozen Shoulder: A Randomized Controlled Trial
Tarun Kumar Somisetty , Hariprasad Seenappa , Subhashish Das , Arun H. Shanthappa
Summary:
A randomized controlled trial comparing intra-articular (IA) platelet-rich plasma (PRP) to corticosteroid (CS) injections in managing frozen shoulder (FS) found that PRP yielded significantly better long-term outcomes. Over a 24-week follow-up period, PRP-treated patients reported greater pain relief, improved range of motion, and better shoulder function as reflected in VAS, SPADI, and QuickDASH scores. The rate of complications was low and comparable between both groups.
PRP demonstrated a sustained therapeutic effect beyond that of corticosteroids, which showed more short-term benefit. Given PRP’s regenerative properties—delivering concentrated growth factors and cytokines directly to the site of injury—it may be a superior alternative, especially for patients contraindicated for steroids or seeking longer-lasting relief without systemic side effects.
Talking Points for Doctors to Patients: Why Choose PRP
